TEL AVIV, Israel, March 12, 2020 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the year ended December 31, 2019 and provides a corporate update.Highlights and achievements during the fourth quarter 2019 and sub

TEL AVIV, Israel, March 12, 2020 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of Aramchol, a liver targeted, oral, SCD1 modulator, currently in a Phase 3 clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis provides today a

NORTH CHICAGO, Ill., March 12, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that the European Commission (EC) has approved VENCLYXTO® (venetoclax) in combination with obinutuzumab for the treatment of adult patients with chronic lymphocytic leukemia (CLL) who were previously untreated. Th

STAINES-UPON-THAMES, United Kingdom, March 12, 2020 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today commented tha

HOLON, Israel, March 12, 2020 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the pricing of an underwritten public offering of 8,333,334 ordinary shares at a price to the public of $9.00 per share. The gross proceeds to Compugen f

NEW YORK, March 12, 2020 /PRNewswire/ -- In response to rising concerns of COVID-19, EmblemHealth, one of the nation's largest non-profit health insurers, announced they are partnering with Medly Pharmacy to provide direct, at-home delivery of prescriptions to their members.Medly Pharmacy is a full-service digital pharmacy that delivers prescription medication rig

NEW YORK, March 12, 2020 /PRNewswire/ -- WebMD Health Corp., an Internet Brands company and the leader in health information services for consumers, physicians, and other healthcare professionals, today announced that it has acquired The StayWell Company, a subsidiary of Merck, known as MSD outside the United States and Canada.  

John Hopkins professor and psychedelics expert Matthew Johnson to act as senior advisor to committee NEW YORK, March 12, 2020 /PRNewswire/ -- 

ALHAMBRA, Calif., March 12, 2020 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, announced today its consolidated financial results for the fourth quarter and year ended December 31, 2019."We closed out 2019 on a high note and are very ple

TOLEDO, Ohio, March 12, 2020 /PRNewswire/ -- Hylant, one of the largest privately held insurance brokers in the U.S., has partnered with Regenexx, a network of leading interventional orthopedics clinics. The partnership allows Hylant to offer its clients Regenexx procedures, giving employees access to non-surgical treatments that replace 70% of what was previously o